Not finding it? Sign in to also search OpenAlex live.
-
Numerical stability and efficiency of response property calculations in density functional theory2023 Letters in Mathematical Physics article Physics and Astronomy Advanced Chemical Physics Studies Open access
Éric Cancès, Michael F. Herbst, Gaspard Kemlin, Antoine Levitt, Benjamin Stamm
6citations -
Anti-C5a Vilobelimab Reduces All-cause Mortality in Critically Ill COVID-19 Patients and in Those With Severe ARDS: A Phase 3 Randomized Double-blind, Placebo-controlled Study
Martin Witzenrath, Alexander P.J. Vlaar, Michael W Bauer, Djillai Annane, L.M.A. Heunks, Bruno Mourvillier, +26 more
2citations -
Recombinant Human C1 Esterase Inhibitor Treatment in Addition to Standard of Care for the Prevention of Cytokine Storm in Hospitalized Patients with COVID-19: A Randomized, Open-Label Trial
Bruno Giannetti, Jin P. Guo, Ashraf Raslan, Jürgen Schaale, Michael Bulitta, Anurag Relan, +1 more
0citations -
Comprehensive spatial profiling of the spleen in murine and human myelofibrosis identifies targetable immune-stromal interactions2025 Zenodo (CERN European Organization for Nuclear Research) dataset Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Bérénice Dugué, Pia Wanner, Mayra L. Ruiz Tejada Segura, Charles Dussiau, Rebekka K. Schneider
0citations -
Comprehensive spatial profiling of the spleen in murine and human myelofibrosis identifies targetable immune-stromal interactions2025 Zenodo (CERN European Organization for Nuclear Research) dataset Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Bérénice Dugué, Wanner Pia, Mayra L. Ruiz Tejada Segura, Charles Dussiau, Rebekka K. Schneider
0citations -
Selective Binding of Heparin/Heparan Sulfate Oligosaccharides to Factor H and Factor H-Related Proteins: Therapeutic Potential for C3 Glomerulopathies2021 Frontiers in Immunology article Immunology and Microbiology Complement system in diseases Open access
Markus A. Loeven, Marissa L. Maciej-Hulme, Cansu Yanginlar, Melanie C. Hubers, Edwin R. Kellenbach, Mark de Graaf, +5 more
21citations -
Initial properdin binding contributes to alternative pathway activation at the surface of viable and necrotic cells2022 European Journal of Immunology article Immunology and Microbiology Complement system in diseases Open access
Mieke F. van Essen, Nicole Schlagwein, Elisa M.P. van den Hoven, Daniëlle J. van Gijlswijk‐Janssen, Rosalie Lubbers, Ramon M. van den Bos, +4 more
8citations -
Monotherapy Treatment with Zaltenibart (OMS906), an Alternative Pathway Masp-3 Inhibitor, Improved Key Hematologic Parameters in Patients with PNH with a Suboptimal Response to Ravulizumab: Interim Results from a Phase 2 Proof-of-Concept Study
Morag Griffin, Richard J. Kelly, Mathilde Gavillet, Petra Muus, Britta Hoechsmann, W. Jason Cummings, +4 more
4citations -
Danicopan As Add-on Therapy to Ravulizumab or Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria: Long-Term Patient-Reported Outcomes from the Phase 3 ALPHA Trial2024 Blood conference-abstract Immunology and Microbiology Complement system in diseases Open access
Caroline Irene Piatek, Jong Wook Lee, Morag Griffin, J Nishimura, Christopher Jordan Patriquin, Hubert Schrezenmeier, +9 more
2citations -
Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 Studies2022 American Journal of Nephrology article Immunology and Microbiology Complement system in diseases Open access
Carla Nester, Gerald B. Appel, Andrew S. Bomback, Koenraad Peter Bouman, H. Terence Cook, Erica Daina, +14 more
70citations -
The 2-year efficacy and safety of iptacopan monotherapy in patients with paroxysmal nocturnal hemoglobinuria with a history of aplastic anemia on concomitant immunosuppressive therapy who entered the roll-over extension program2025 Blood conference-abstract Immunology and Microbiology Complement system in diseases Open access
Régis Peffault de Latour, Anna Gayà, Morag Griffin, Bing Han, Austin Gladston Kulasekararaj, Jaroslaw Pawel Maciejewski, +11 more
0citations -
Management of recurrent C3 glomerulopathy after kidney transplantation2026 Nephrology Dialysis Transplantation article Immunology and Microbiology Complement system in diseases Open access
Hernando Trujillo, Teresa Cavero, Sarah Margaret Moran, Şafak Mirioğlu, Annette N. Bruchfeld, Stefanie Steiger, +7 more
0citations -
Plain Language Summary of PEGASUS, a Study Comparing Pegcetacoplan with Eculizumab for 16 Weeks in People with Paroxysmal Nocturnal Hemoglobinuria2023 Future Rare Diseases article Immunology and Microbiology Complement system in diseases Open access
Morag Griffin, Jeff Szer, Ilene Ceil Weitz, Alexander Röth, Britta Höchsmann, Jens Panse, +11 more
0citations -
Thrombosis and Encapsulated Bacterial Infection Rates in Patients with Paroxysmal Nocturnal Hemoglobinuria Who Received Pegcetacoplan: Nearly 3 Years of Post-Marketing Experience2024 Blood conference-abstract Immunology and Microbiology Complement system in diseases Open access
Gloria Frances Gerber, Richard Kelly, Hisakazu Nishimori, Regina Horneff, Peter Hillmen, Uchendu Orizu Uchendu, +2 more
1citations -
Long-term safety and efficacy of iptacopan in patients with paroxysmal nocturnal hemoglobinuria: 4- and 5-year follow-up of patients from Phase 2 studies who entered the roll-over extension program
Antonio Maria Risitano, Camilla Frieri, Bor‐Sheng Ko, Lily Wong Lee Lee, Alexander Röth, Flore Sicre de Fontbrune, +8 more
0citations